Márcio Lubini

Statistics

Publications

Citations

117

H-Index

Active since

2022

Affiliations

Universidade de Passo Fundo(Current)

Universidade Federal de Juiz de Fora

Universidade de São Paulo

Pontifícia Universidade Católica de Campinas

Márcio Lubini is an author at Universidade de Passo Fundo specializing in inflammatory bowel disease therapy, clinical sciences, and gastroenterology.

ORCID

Publications per year

2022–2024

Publications

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study

Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz et al. · BMC Gastroenterology · 2022 · 24 citations · Full text

Medicine, Clinical Sciences, Immunology +16

Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study

Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Matheus Freitas Cardoso de Azevedo et al. · Crohn s & Colitis 360 · 2024 · 10 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

1–3 of 3